Cargando…
Medication non-adherence in inflammatory bowel diseases is associated with disability
BACKGROUND/AIMS: Medication non-adherence is common in inflammatory bowel diseases (IBD). The short-term consequences of non-adherence include increased disease relapse but the long-term impact upon patients in terms of daily functional impairment are less well characterized. Identifying negative ou...
Autores principales: | Perry, Jonathan, Chen, Andy, Kariyawasam, Viraj, Collins, Glen, Choong, Chee, Teh, Wei Ling, Mitrev, Nikola, Kohler, Friedbert, Leong, Rupert Wing Loong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association for the Study of Intestinal Diseases
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223449/ https://www.ncbi.nlm.nih.gov/pubmed/30301333 http://dx.doi.org/10.5217/ir.2018.00033 |
Ejemplares similares
-
Dual biologic therapy with ocrelizumab for multiple sclerosis and vedolizumab for Crohn’s disease: A case report and review of literature
por: Au, Michael, et al.
Publicado: (2022) -
Depression, anxiety and stress among patients with inflammatory bowel disease during the COVID-19 pandemic: Australian national survey
por: Cheema, Madiha, et al.
Publicado: (2021) -
Medication adherence in inflammatory bowel disease
por: Chan, Webber, et al.
Publicado: (2017) -
Determining efficacy of dynamic multimedia bowel preparation instructions versus standard instructions on adenoma detection and patient reported measures (DIGICLEAN trial): a study protocol for a multicentre, colonoscopist-blinded, randomised controlled trial
por: Au, Michael, et al.
Publicado: (2023) -
Review of exclusive enteral therapy in adult Crohn’s disease
por: Mitrev, Nikola, et al.
Publicado: (2021)